Plain-English translation of NCT07634016 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that gathers information from the medical records and routine clinical care of people with psoriasis worldwide. Rather than testing a new medication, researchers are collecting and analyzing real-world data to understand how psoriasis is currently being diagnosed, treated, and managed across different healthcare systems.
Psoriasis affects millions of people globally, but we still have gaps in understanding how the condition is managed across different countries and healthcare settings. This study aims to learn from real-world patient experiences and medical records to identify patterns in care, treatment effectiveness, and patient outcomes.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing researchers to access and review your medical records and information from your routine psoriasis care visits. This is a record-based study, so you won't need to take new medications or attend special study visits — researchers will simply collect and analyze existing data from your healthcare provider's records spanning from January 2020 onwards.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Switzerland
Enrollment target
~9,600 participants
Started
January 2025
Primary completion
December 2029
Age range
14 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Julia-Tatjana Maul
University of Zurich
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.